I
Invivyd Inc
NASDAQ:IVVD
Invivyd Inc
NASDAQ:IVVD
Price:
1.37
USD
-9.27%
Market Closed
Market Cap:
$386.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Invivyd Inc
NASDAQ:IVVD
|
US |
|
Embelton Ltd
ASX:EMB
|
AU |
|
G
|
Goviex Uranium Inc
SWB:7GU
|
CA |
|
B
|
Batu Kawan Bhd
KLSE:KAWAN
|
MY |
|
Merchants Bancorp
NASDAQ:MBIN
|
US |
|
X
|
Xiaomi Corp
SWB:3CP
|
CN |
|
P
|
Pan Electronics India Ltd
BSE:517397
|
IN |
|
Beijing Sifang Automation Co Ltd
SSE:601126
|
CN |
|
Leoni AG
XETRA:LEO
|
DE |
|
X
|
Xplora Technologies AS
OSE:XPLRA
|
NO |
|
Indo Count Industries Ltd
NSE:ICIL
|
IN |
|
K
|
Ksfinance Group JSC
VN:KSF
|
VN |
|
Novatek Microelectronics Corp
TWSE:3034
|
TW |
|
A
|
Allego NV
NYSE:ALLG
|
NL |
|
T
|
Thai Setakij Insurance PCL
SET:TSI
|
TH |
|
H
|
Herald Holdings Ltd
HKEX:114
|
HK |
|
D
|
Dingyi Group Investment Ltd
HKEX:508
|
HK |
|
D
|
Dexin China Holdings Company Ltd
HKEX:2019
|
CN |
|
Summit Therapeutics Inc
NASDAQ:SMMT
|
US |
|
Digital Ally Inc
NASDAQ:DGLY
|
US |
|
Hawkins Inc
NASDAQ:HWKN
|
US |
|
W
|
Wahana Inti Makmur Tbk PT
IDX:NASI
|
ID |
|
P
|
Prosperous Future Holdings Ltd
HKEX:1259
|
CN |
|
A
|
Alfi Inc
OTC:ALFIQ
|
US |
Multiples-Based Value
The Multiples-Based Value of one IVVD stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.37 USD, Invivyd Inc is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IVVD Multiples-Based Value
LOCKED
Multiples Across Competitors
IVVD Competitors Multiples
Invivyd Inc Competitors
Invivyd Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
I
|
Invivyd Inc
NASDAQ:IVVD
|
386.3m USD | 7.2 | -7.4 | -2.9 | -2.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.1 | 88.4 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.7 | 19.6 | 12.3 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.2 | 27.8 | 20.9 | 21.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.2 | 35.1 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
